2020 Health & Nutrition Finalists
Emovo Care is a connected care provider developing a robotic hand orthosis to deliver care at home after stroke.
HexagonFab develops biological sensors for rapid and highly sensitive detection of biological substances like proteins, DNA or small molecules, with portable and affordable readers. This technology eliminates the need for lengthy and expensive lab processes in biotech R&D and drug manufacturing.
Enabling the cell and gene therapy market and patient access by automating its manufacturing.
Limula Biotech's patented technology is made up of a manufacturing unit and single use kit which allows healthcare providers to safely manufacture cell and gene therapy (CGT) directly at the hospital, thus bringing the production close to the patient and enabling fair access to these therapies.
MotionTech has developed the first silicone 3D printing technology able to print orthopaedic-grade silicone. Through their service model, orthopaedic technicians place orders by 3D scanning the body part of their patient for which they want to a tailored device. MotionTech then designs the product and prints it in their production facility.
Nemis Technologies AG
NEMIS' kits are a game-changer for mass application and have the potential to transform the field of microbial detection. Thanks to their novel AquaSpark technology platform, a broad range of pathogenic bacteria can be detected and with that the needs of various segments addressed.
Neurosoft Bioelectronics is developing the next generation of implantable electrical interfaces for the nervous system.
NeoKidney is the first hemodialysis device that is truly portable, physiological and cost-effective, all at the same time. Thanks to its features, the solution is positively impacting the patients' quality of life while providing substantial cost savings to both patients and healthcare systems.
REA, a spinoff from EPFL, has developed the first at-home test for preterm birth diagnostics. REA’s Smart Pad analyzes vaginal secretions, screening for proteins that are indicative of birth. A negative test result reassures a pregnant woman that she won’t give birth in the next 7 days and relieves her from stress and costly visits to the hospital.
TERAPET, a CERN start-up, is developing and commercializing innovative solutions for a safer, more precise and time-saving proton therapy for cancer treatment. Their product is a novel medical device which enables medical doctors for the first time to monitor the delivered proton dose inside the patients during cancer treatment: in-vivo, non-invasive, in 3D and real-time. With our solutions, we will ensure that every patient receives the right dose, every time.
URODEA's patent-pending technology is the world’s first non-invasive solution for urinary retention. Their product will be a handheld device, which aids in emptying the bladder by generating a urine flow while avoiding contact with urine.